Page last updated: 2024-08-18

pyrroles and losartan potassium

pyrroles has been researched along with losartan potassium in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, LL; Cheung, JY; Lynch, CJ; Miller, BA1
Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L1
Cortes, JE; Estrov, Z; Gaikwad, A; Kantarjian, HM; Manshouri, T; Nussenzveig, RH; Prchal, J; Quintás-Cardama, A; Verstovsek, S1
Chiang, CK; Hsu, SP; Huang, JW; Hung, KY; Pai, MF; Peng, YS; Wu, KD; Yang, SY1
Boven, E; Broxterman, HJ; de Haas, RR; Haanen, JB; Hoekman, K; Kuik, DJ; Schuurhuis, GJ; van Cruijsen, H; van den Eertwegh, AJ; van der Veldt, AA; van Hinsbergh, VW; Verheul, HM; Vroling, L1
Dounousi, E; Ioannou, K; Kelesidis, A; Kotzadamis, N; Papakonstantinou, S; Tsakiris, D; Tsouchnikas, I; Xanthopoulou, K1
Gong, K; Li, T; Ning, X; Wang, X; Wu, P; Zhang, C; Zhang, N1
Brugarolas, J; Bruick, RK; Chang, J; Chen, W; Christie, A; Courtney, K; Frenkel, E; Gardner, KH; Geiger, H; Hao, G; Hill, H; Holloman, E; Homayoun, F; Hwang, TH; Josey, JA; Joyce, A; Kapur, P; Kim, MS; Ma, Y; McKay, RM; Patel, N; Pavia-Jimenez, A; Pedrosa, I; Reeves, C; Rizzi, JP; Sun, X; Wallace, EM; Wong, T; Xie, XJ; Xie, Y; Yell, P; Yousuf, Q; Zhang, H; Zojwalla, N1
Fu, X; Jiang, C; Li, H; Meng, Y; Tang, Y; Yan, F; Yu, L; Zhang, M1

Trials

1 trial(s) available for pyrroles and losartan potassium

ArticleYear
Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
    American journal of nephrology, 2009, Volume: 29, Issue:5

    Topics: Aged; Anemia; Atorvastatin; Drug Synergism; Erythropoietin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Recombinant Proteins; Renal Dialysis; Tumor Necrosis Factor-alpha

2009

Other Studies

9 other study(ies) available for pyrroles and losartan potassium

ArticleYear
Erythropoietin modulation of intracellular calcium: a role for tyrosine phosphorylation.
    Cell calcium, 1994, Volume: 16, Issue:6

    Topics: Adult; Alkaloids; Analog-Digital Conversion; Biological Transport; Bucladesine; Calcium; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Erythroid Precursor Cells; Erythropoietin; Genistein; Humans; Image Processing, Computer-Assisted; Indoles; Intercellular Signaling Peptides and Proteins; Intracellular Fluid; Isoflavones; Isoquinolines; Naphthalenes; Peptides; Phosphorylation; Polycyclic Compounds; Protein Kinase C; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pyrroles; Signal Transduction; Staurosporine; Sulfonamides; Tetradecanoylphorbol Acetate; Videotape Recording; Wasp Venoms

1994
Recent changes to FDA-approved labeling.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Sep-01, Volume: 61, Issue:17

    Topics: Acetamides; Aminoquinolines; Atazanavir Sulfate; Atorvastatin; Botulinum Toxins, Type A; Dosage Forms; Drug Labeling; Epoetin Alfa; Erythropoietin; Heptanoic Acids; Humans; Imiquimod; Insulin; Insulin Lispro; Mandelic Acids; Oligopeptides; Oseltamivir; Pyridines; Pyrroles; Recombinant Proteins; United States; United States Food and Drug Administration

2004
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
    European journal of heart failure, 2006, Volume: 8, Issue:5

    Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines

2006
The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation.
    Cancer science, 2008, Volume: 99, Issue:6

    Topics: Animals; Apoptosis; Blotting, Western; Bone Marrow; Cell Cycle; Cell Nucleus; Cell Proliferation; Cells, Cultured; Erythroid Precursor Cells; Erythropoietin; Flow Cytometry; Humans; Immunoprecipitation; Janus Kinase 2; Membrane Potential, Mitochondrial; Mice; Mutation; Phosphorylation; Piperidines; Polycythemia Vera; Protein Kinase Inhibitors; Protein Transport; Pyrimidines; Pyrroles; Receptors, Erythropoietin; Signal Transduction; STAT3 Transcription Factor

2008
Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
    Angiogenesis, 2009, Volume: 12, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Agents; Biomarkers, Tumor; Blood Cell Count; Carcinoma, Renal Cell; Endothelial Cells; Erythropoietin; Female; Flow Cytometry; Hematopoietic Stem Cells; Humans; Indoles; Kidney Neoplasms; Kinetics; Male; Middle Aged; Pyrroles; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A

2009
Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients.
    Nephrology (Carlton, Vic.), 2009, Volume: 14, Issue:6

    Topics: Aged; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Erythropoietin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrroles; Renal Dialysis

2009
The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Animals; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Erythropoietin; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Indoles; Kidney Neoplasms; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Protein Kinase Inhibitors; Pyrroles; Receptors, Erythropoietin; Recombinant Proteins; Signal Transduction; Sunitinib

2012
Targeting renal cell carcinoma with a HIF-2 antagonist.
    Nature, 2016, 11-03, Volume: 539, Issue:7627

    Topics: Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Basic Helix-Loop-Helix Transcription Factors; Binding Sites; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Erythropoietin; Female; Gene Expression Regulation, Neoplastic; Humans; Indans; Indoles; Kidney Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Mutation; Pyrroles; Reproducibility of Results; Sulfones; Sunitinib; Xenograft Model Antitumor Assays

2016
Erythropoietin improves hypoxic-ischemic encephalopathy in neonatal rats after short-term anoxia by enhancing angiogenesis.
    Brain research, 2016, 11-15, Volume: 1651

    Topics: Angiogenesis Inducing Agents; Animals; Animals, Newborn; Cognition; Disease Models, Animal; Erythropoietin; Hippocampus; Hypoxia; Hypoxia-Ischemia, Brain; Indoles; Male; Pyrroles; Random Allocation; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; White Matter

2016